KLDO — Kaleido Biosciences Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$16.78m
- $1.10m
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE
Brief: Kaleido Biosciences Reports Second Quarter 2019 Financial Results And Provides Corporate Update
Brief: Kaleido Biosciences Reports Q1 Loss Per Share Of $1.56
Brief: Kaleido Biosciences Announces Presentation Of Data For Therapies For Hyperammonemia
Brief: Kaleido Biosciences Shares Open 14.7 Pct Below IPO Price In Debut On Nasdaq
NASDAQ RESUMED
NASDAQ TRADE HALT REASON NOT AVAILABLE
Brief: Kaleido Biosciences Announces Pricing Of Initial Public Offering
Brief: Kaleido Biosciences Says Co Anticipates That The IPO Price Will Be Between $20 And $22 Per Share